Contact this trialFirst, we need to learn more about you.
Ghrelin Receptor Agonist
Anamorelin Hydrochloride for Cancer Cachexia
Recruiting1 awardPhase 3
Ogden, Utah
This trial is testing if a new drug, anamorelin HCl, is better than placebo at treating cachexia in patients with advanced lung cancer. The trial will last 24 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.